An American company is developing a treatment to combat loss of hearing.
Based on the concept of regenerative medicine, this drug – still in the clinical trial phase – aims to regenerate the cells responsible for hearing.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
